Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade. The post CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low appeared first on InvestorPlace.

CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low

CTO Andrew Toy has a great tool in the Clover Assistant, which can cut the costs of treating chronic conditions among aging patients. But will he get a chance to deploy it?

The Two Faces of Clover Health

NASHVILLE, Tenn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a technology company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, and President, Andrew Toy, will present at the 40th Annual JP Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022, at 5:15 p.m. Eastern Time.

Clover Health to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2022

Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here.

The Steep Drop In Clover Health Stock Sets up an Entry Opportunity

Clover Health's market cap dropped 74% in 2021. Heading into 2022, CLOV stock is not the $2 billion market cap to buy.

Clover Health Is Not the $2 Billion Stock to Buy for 2022

Fastly

Wayfair

2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year.

3 Sleeper Stocks to Buy Now Before 2022 Rolls In

In the latest trading session, Clover Health Investments, Corp. (CLOV) closed at $4.09, marking a -0.24% move from the previous day.

Clover Health Investments, Corp. (CLOV) Stock Sinks As Market Gains: What You Should Know

Investors need to pay close attention to Clover Health (CLOV) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Clover Health (CLOV) Stock?

AMC Entertainment

Vinco Ventures

GameStop

Canoo

Ocugen, Inc.

Tilray Brands

Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear.

7 Meme Stocks to Sell Before They Lose Momentum

BlackBerry

Bed Bath & Beyond

SNDL Inc.

Tesla

Wish

XpresSpa Group

Zomedica

Retail investors continue to drive the price of meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022 The post Top 10 Meme Stocks of 2021 and How They'll Fare in 2022 appeared first on InvestorPlace.

Top 10 Meme Stocks of 2021 and How They'll Fare in 2022

Limelight Networks

Metacrine

3 penny stocks to watch after Fed Chair Powells press conference. The post 3 Penny Stocks To Watch After Jerome Powell's Fed Announcement appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks To Watch After Jerome Powell's Fed Announcement

CLOV stock has underperformed in 2021, became a meme stock, and now has many risks and challenges to face to reach profitability. The post Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope appeared first on InvestorPlace.

Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope

Carnival

DraftKings

MicroVision

Peloton

Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.

7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out

NASHVILLE, Tenn., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV) (“Clover”), a technology company committed to improving health equity for America's underserved seniors, announced that it will provide clinicians using the Clover Assistant with access to comprehensive renal care coordination and services to support disease management among their patients who have been diagnosed with chronic kidney disease (CKD). As part of the program, Clover is partnering with value-based kidney care provider Cricket Health to offer patients comprehensive, personalized kidney care.

Clover Health Launches New Clinical Program Targeting Chronic Kidney Disease in Partnership with Cricket Health

CLOV stock continues to punish long-suffering shareholders as it losses value. The latest public offering at the low-ball price of $5.75 is another nail in the coffin.

As Clover Health Stock Gets Diluted, Stockholders Are Giving Up

Camber Energy

GSX Techedu Inc.

Which penny stocks are you watching right now? The post Making a Penny Stocks Watchlist?

Making a Penny Stocks Watchlist? 3 You Need to Know About

CLOV stock is saddled with issues that include a declining share price and operational issues that are only getting more troublesome. The post Clover Health Is Now a Penny Stock, Denoting Its Serious Decline appeared first on InvestorPlace.

Clover Health Is Now a Penny Stock, Denoting Its Serious Decline

Clover Health has done a great job appealing to the biggest CLOV stock fans on Reddit, but great publicity doesn't make it profitable. The post Clover Health Appeals to Its Base, But Profits Are in the Distant Future appeared first on InvestorPlace.

Clover Health Appeals to Its Base, But Profits Are in the Distant Future

Likely to languish at or below $5 per share for a while, skip out for now with CLOV stock. The post With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock appeared first on InvestorPlace.

With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock

The company reported earnings and announced a common stock offering last month.

Why Clover Health Tanked 33.9% in November

15 out of 20 top institutional shareholders are buying CLOV at the dip. Despite the lack of urgency for raising capital, management's decision to sell equity is rational, sparing the risk of more dilution if share prices drop.

Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out

November was brutal for shareholders of Clover Health. CLOV stock lost close to 40% of its value.

If November Is Any Indication, Clover Health Is on Life Support

The Clover Assistant is meant to align incentives between health care providers and managed care companies, which could cut costs and create profits. That's what CLOV stock investors should focus on.

The Engine Boosting Clover Health Stock is a CTO Working to Disrupt Medicare

Last rites for Clover Health Investments seem premature, but CLOV stock is being challenged off and on the price chart. The post The Clover Health Dilemma: Is it a Good Buy or Goodbye?

News for Clover Health Investments Stock (CLOV)